tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Cautious Hold on Cellectis SA Amid Anticipated Data Releases and Strategic Developments
PremiumRatingsCautious Hold on Cellectis SA Amid Anticipated Data Releases and Strategic Developments
3M ago
Cellectis SA: Hold Rating Amid Stable Financials and Promising Collaborations, Yet Cautious Outlook Due to Market and Clinical Uncertainties
Premium
Ratings
Cellectis SA: Hold Rating Amid Stable Financials and Promising Collaborations, Yet Cautious Outlook Due to Market and Clinical Uncertainties
3M ago
Cellectis price target lowered to $4 from $5 at Barclays
Premium
The Fly
Cellectis price target lowered to $4 from $5 at Barclays
3M ago
CLLS Earnings this Week: How Will it Perform?
PremiumPre-EarningsCLLS Earnings this Week: How Will it Perform?
3M ago
Cellectis Unveils Gene Editing Innovations at ASGCT Meeting
Premium
Company Announcements
Cellectis Unveils Gene Editing Innovations at ASGCT Meeting
3M ago
Cellectis S.A. Updates UCART Pipeline with Phase 2 Trial Details
Premium
Company Announcements
Cellectis S.A. Updates UCART Pipeline with Phase 2 Trial Details
4M ago
Cellectis reports Q4 EPS (64c) vs (17c) last year
PremiumThe FlyCellectis reports Q4 EPS (64c) vs (17c) last year
5M ago
Cellectis Unveils Innovative ‘Smart CAR T’ Strategy to Boost Solid Tumor Therapy
Premium
Company Announcements
Cellectis Unveils Innovative ‘Smart CAR T’ Strategy to Boost Solid Tumor Therapy
5M ago
Iovance Biotherapeutics (IOVA) Forecasts Strong Growth Due to Flagship Treatment
Premium
Market News
Iovance Biotherapeutics (IOVA) Forecasts Strong Growth Due to Flagship Treatment
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100